For cancer patients, traditional Medicare is better than Medicare Advantage

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Now that the Medicare re-enrollment period has arrived (Oct. 15-Dec. 7), senior Americans are exposed to ubiquitous advertisements, phone calls, and other mechanisms to convince them to enroll in Medicare Advantage rather than traditional Medicare plans. 

To access this subscriber-only content please log in or renew your subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
Hagop M. Kantarjian, MD
Chair and professor, Department of Leukemia, Samsung Distinguished Leukemia Chair in Cancer Medicine, MD Anderson Cancer Center; Fellow of health policy, Baker Institute for Public Policy, Rice University
Mary Alma Welch, PAC, MMSc
Associate director, Leukemia Advanced Practice Programs, Inpatient medical director, Leukemia, Department of Leukemia, MD Anderson Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

We unexpectedly lost a dear friend and colleague, Dr. Cullen Taniguchi, in mid-November. Dr. Taniguchi was an exceptional and compassionate clinician, brilliant scientist, and nurturing mentor. Above all, he was a dedicated and loving husband, father, son, and brother. We deeply mourn his loss, but we forever cherish the memories and indelible legacy that he leaves with us. 
Hagop M. Kantarjian, MD
Chair and professor, Department of Leukemia, Samsung Distinguished Leukemia Chair in Cancer Medicine, MD Anderson Cancer Center; Fellow of health policy, Baker Institute for Public Policy, Rice University
Mary Alma Welch, PAC, MMSc
Associate director, Leukemia Advanced Practice Programs, Inpatient medical director, Leukemia, Department of Leukemia, MD Anderson Cancer Center

Login